Treatment of steroid-dependent minimal change-nephrotic syndrome wity mycophenolate mofetil;Tratamiento del síndrome nefrótico córtico-dependiente por lesiones mínimas con micofenolato mofetil

Nefrologia

Volumn 24, Issue 1, 2004, Pages 79-82

  Norona B ^a   Valentin M ^a   Gutierrez E ^a   Praga, M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Mycophenolate mofetil; Nephrotic syndrome; Prednisone

Indexed keywords

CHLORAMBUCIL; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; CORTICOSTEROID; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DRUG EFFECT; HUMAN; LABORATORY TEST; MALE; NEPHROTIC SYNDROME; RELAPSE; REMISSION; SIDE EFFECT; TREATMENT OUTCOME; LIPOID NEPHROSIS;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; NEPHROSIS, LIPOID;

EID: 3042785073     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. The primary nephrotic syndrome in children: identification of patients with minimal change nephrotic syndrome from initial response to prednisona. A report of the International Study of Kidney Disease in children. J Pediatr 98: 561-564, 1981.
2. Cyclophoshamide treatment of steroid dependent nephrotic syndrome: comparison of eight week with 12 week course. Report of Arbeitsgemeinschaft für Pediatrische Nephrologie. Arch Dis Child 62: 1102-1106, 1987.
3. Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ: Steroid-responsive nephrotic syndrome of chilhood: a long term study of clinical course, histopathology, efficacy of ciclophosphamide therapy and effects on growth. Am J Kidney Dis 9: 108-114, 1987.
4. Grupe WE, Makker SP, Ingelfinger JR: Chlorambucil treatment of frequently relapsing nephrotic syndrome. N Engl J Med 295: 746-749, 1976.
5. Niaudet P, Broyer M, Habib R: Treatment of idiopathic syndrome with cyclosporin A in children. Clin Nephrol 35 (Supl. 1): 31-36, 1991.
6. Hoyer JR: Idiopathic nephrotic syndrome with minimal glomerular changes. En: Brenner BM, Stein JH: contemporany issues in nephrology: nephrotic syndrome. Churchill Livingstone, New York, 1982.
7. Allison A, Eugui E: Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47: 85-118, 2000.
8. Choi M, Eustace J, Giménez L, Atta M, Schell P, Sothinathan R, Briggs W: Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 61: 1098-1114, 2002.
9. Day CJ, Cockwell P, Lipkin G, Savage C, Howie A, Adu D: Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 17: 2011-2013, 2002.